UBS Group’s Liminal BioSciences Inc. Common Shares LMNL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-715
| Closed | -$4.49K | – | 8928 |
|
|
2023
Q2 | $4.49K | Buy |
715
+667
| +1,390% | +$4.19K | ﹤0.01% | 6444 |
|
|
2023
Q1 | $182 | Sell |
48
-195
| -80% | -$739 | ﹤0.01% | 8050 |
|
|
2022
Q4 | $803 | Buy |
243
+242
| +24,200% | +$800 | ﹤0.01% | 8866 |
|
|
2022
Q3 | $0 | Sell |
1
-764
| -100% | – | ﹤0.01% | 10056 |
|
|
2022
Q2 | $4K | Buy |
765
+35
| +5% | +$183 | ﹤0.01% | 8154 |
|
|
2022
Q1 | $7K | Buy |
730
+573
| +365% | +$5.5K | ﹤0.01% | 7831 |
|
|
2021
Q4 | $2K | Buy |
157
+156
| +15,600% | +$1.99K | ﹤0.01% | 8743 |
|
|
2021
Q3 | $0 | Sell |
1
-562
| -100% | – | ﹤0.01% | 9007 |
|
|
2021
Q2 | $22K | Buy |
563
+562
| +56,200% | +$22K | ﹤0.01% | 6155 |
|
|
2021
Q1 | $0 | Sell |
1
-2
| -67% | – | ﹤0.01% | 8367 |
|
|
2020
Q4 | $0 | Sell |
3
-77
| -96% | – | ﹤0.01% | 7761 |
|
|
2020
Q3 | $9K | Buy |
80
+79
| +7,900% | +$8.89K | ﹤0.01% | 6092 |
|
|
2020
Q2 | $0 | Sell |
1
-148
| -99% | – | ﹤0.01% | 7412 |
|
|
2020
Q1 | $10K | Buy |
149
+32
| +27% | +$2.15K | ﹤0.01% | 6036 |
|
|
2019
Q4 | $10K | Buy |
+117
| New | +$10K | ﹤0.01% | 6230 |
|